EXECUTIVE EMPLOYMENT AGREEMENT BY AND BETWEEN HORIZON THERPEUTICS PUBLIC PLC AND HORIZON THERAPEUTICS USA, INC. AND ELIZABETH H. Z. THOMPSONExecutive Employment Agreement • May 5th, 2021 • Horizon Therapeutics Public LTD Co • Pharmaceutical preparations • Illinois
Contract Type FiledMay 5th, 2021 Company Industry JurisdictionThis Executive Employment Agreement (hereinafter referred to as the “Agreement”), is entered into by and between Horizon Therapeutics PLC., an Irish Public Limited Company, and its wholly owned subsidiary, Horizon Therapeutics USA, Inc., a Delaware corporation, having a principal place of business at 1 Horizon Way, Deerfield IL 60015, (hereinafter referred to together as the “Company”) and Elizabeth H. Z. Thompson (hereinafter referred as to the “Executive”). The terms of this Agreement shall be effective commencing March 15, 2021 (the “Effective Date”).
THIRD SUPPLEMENTAL INDENTUREThird Supplemental Indenture • May 5th, 2021 • Horizon Therapeutics Public LTD Co • Pharmaceutical preparations • New York
Contract Type FiledMay 5th, 2021 Company Industry JurisdictionTHIRD SUPPLEMENTAL INDENTURE (this “Supplemental Indenture”), dated as of March 15, 2021, between Viela Bio, Inc., a Delaware corporation (the “Guaranteeing Entity”), which is a subsidiary of the Issuer (as defined below), and U.S. Bank National Association, as trustee under the Indenture referred to below (the “Trustee”).